Decibel Cannabis Company (TSE:DB)
:DB
Want to see TSE:DB full AI Analyst Report?
Top Page
Decibel Cannabis Company
(DB)
Select Model
Select Model
Rating:55Neutral
Price Target:
C$0.13
▲(33.00% Upside)
Action:ReiteratedDate:04/21/26
The score is held back primarily by the 2025 profitability and margin deterioration despite revenue growth, partially offset by improved free cash flow and a not overly levered balance sheet. Technicals are moderately supportive with price above key moving averages and positive MACD, while valuation offers limited support due to a negative P/E and no dividend yield.
Positive Factors
Revenue & cash flow improvement
Sustained revenue growth to 2025 combined with sharply improved free cash flow in 2025 signals improving operating conversion. Positive operating and free cash flow in 2022–2025 provides durable internal funding for working capital, modest reinvestment, and lower financing dependence over the next several quarters.
Negative Factors
Margin collapse and profitability swing
A dramatic gross margin drop and reversal to operating and net losses in 2025 indicates structural pressure on pricing, product mix or cost control. Such a large deterioration undermines earnings sustainability, reduces reinvestment capacity and raises the risk of further margin compression absent durable operational fixes.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & cash flow improvement
Sustained revenue growth to 2025 combined with sharply improved free cash flow in 2025 signals improving operating conversion. Positive operating and free cash flow in 2022–2025 provides durable internal funding for working capital, modest reinvestment, and lower financing dependence over the next several quarters.
Read all positive factors
Decibel Cannabis Company (DB) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$69.23M
Dividend YieldN/A
Average Volume (3M)258.21K
Price to Earnings (P/E)―
Beta (1Y)0.37
Revenue Growth21.81%
EPS Growth-127.42%
CountryCA
Employees171
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-32.95
Shares Outstanding576,900,000
10 Day Avg. Volume297,792
30 Day Avg. Volume258,209
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)1.02
Price to Sales (P/S)0.56
P/FCF Ratio11.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.23Price Target Upside133.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.02
Revenue Forecast (FY)C$134.28M
Decibel Cannabis Company Business Overview & Revenue Model
Company Description
Decibel Cannabis Company Inc. engages in the cultivation, processing, production, and retail sale of cannabis products in Canada. It offers cannabis flower, cannabis pre-rolls, and cannabis biomass to licensed producers in Canada. The company is a...
How the Company Makes Money
Decibel Cannabis Company makes money primarily by selling finished cannabis products into Canada’s regulated legal market. Its core revenue streams generally include: (1) wholesale sales of branded cannabis products (e.g., dried flower and other f...
Decibel Cannabis Company Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
56
Neutral
Cash Flow
63
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 112.72M | 92.54M | 106.22M | 79.33M | 52.45M |
| Gross Profit | 17.49M | 37.58M | 38.77M | 26.43M | 28.17M |
| EBITDA | -10.80M | 21.53M | 3.25M | 2.26M | 9.45M |
| Net Income | -2.92M | 9.46M | -1.77M | -4.46M | 1.74M |
Balance Sheet | |||||
| Total Assets | 141.60M | 151.86M | 142.99M | 140.88M | 125.93M |
| Cash, Cash Equivalents and Short-Term Investments | 7.49M | 7.00M | 3.48M | 2.97M | 1.92M |
| Total Debt | 44.16M | 48.32M | 48.52M | 48.39M | 49.90M |
| Total Liabilities | 79.25M | 87.14M | 96.79M | 93.67M | 75.19M |
| Stockholders Equity | 62.35M | 64.72M | 46.20M | 47.21M | 50.73M |
Cash Flow | |||||
| Free Cash Flow | 5.47M | 3.21M | 4.92M | 4.44M | -20.39M |
| Operating Cash Flow | 7.46M | 3.98M | 7.08M | 8.26M | -17.15M |
| Investing Cash Flow | -1.98M | 1.19M | -2.13M | -3.76M | -3.23M |
| Financing Cash Flow | -4.98M | -1.65M | -4.43M | -3.45M | 18.47M |
Decibel Cannabis Company Technical Analysis
Positive
0.10
Price Trends
0.11
Positive
0.11
Positive
0.11
Positive
Market Momentum
<0.01
Negative
58.36
Neutral
77.78
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:DB, the sentiment is Positive. The current price of 0.1 is below the 20-day moving average (MA) of 0.13, below the 50-day MA of 0.11, and below the 200-day MA of 0.11, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 58.36 is Neutral, neither overbought nor oversold. The STOCH value of 77.78 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:DB.
Decibel Cannabis Company Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
59 Neutral | C$36.11M | -3.47 | -19.10% | ― | 7.54% | 24.81% | |
55 Neutral | C$69.23M | -11.94 | 12.78% | ― | 21.81% | -127.42% | |
54 Neutral | C$117.19M | -1.25 | -275.39% | ― | 2.51% | -0.85% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | C$63.99M | -3.54 | -80.81% | ― | -9.38% | -24.71% | |
45 Neutral | C$58.57M | -0.85 | 136.59% | ― | ― | ― | |
41 Neutral | C$19.26M | -44.16 | -2.15% | ― | 24.10% | 94.52% |
* Healthcare Sector Average
TSE:DB
Decibel Cannabis Company
0.12
0.05
71.43%
TSE:LEEF
Leef Brands
0.22
0.05
29.41%
TSE:CWEB
Charlotte's Web Holdings
0.73
0.62
534.78%
TSE:LABS
MediPharm Labs
0.09
0.00
0.00%
TSE:PLTH
Planet 13 Holdings
0.20
-0.18
-47.30%
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.15
-0.06
-27.50%
Decibel Cannabis Company Corporate Events
Financial Disclosures
Decibel Cannabis to Release Q4 2025 Results on April 16, 2026
Neutral
Apr 8, 2026
Decibel Cannabis Company plans to release its fourth quarter 2025 financial results before markets open on April 16, 2026, and will hold a conference call later that morning to discuss its performance. The announcement signals an upcoming update o...
Business Operations and StrategyM&A Transactions
Decibel to Sell Creston Site and Consolidate Cannabis Cultivation for Efficiency Gains
Positive
Feb 25, 2026
Decibel Cannabis Company Inc. has agreed to sell its Creston, British Columbia property for about $2.5 million and will use the proceeds to repay a portion of its recently announced term debt. As part of the move, the company will consolidate cult...
Business Operations and StrategyExecutive/Board Changes
Decibel Grants 11.5 Million Stock Options to Bolster Employee Retention
Positive
Feb 11, 2026
Decibel Cannabis Company has granted 11,537,223 stock options to certain officers and employees, exercisable at $0.10 per share, matching the February 10, 2026 TSX Venture Exchange closing price. The options vest in three equal annual installments...
Business Operations and StrategyPrivate Placements and Financing
Decibel Secures $61 Million ATB Credit Deal to Fund Growth and Refinance Debt
Positive
Feb 10, 2026
Decibel Cannabis Company has secured new credit facilities totaling $61 million from ATB Financial and ATB Cormark Capital Markets, refinancing its existing debt and extending maturities to February 2030. The package comprises a $40 million first ...
Business Operations and StrategyPrivate Placements and Financing
Decibel Secures $61 Million ATB Credit Facility to Extend Debt Maturities and Fund Growth
Positive
Feb 10, 2026
Decibel Cannabis Company has secured new credit facilities totaling $61 million from ATB Financial and ATB Cormark Capital Markets, refinancing existing debt and extending its maturities to February 2030. The financing package comprises a $40 mill...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.